Organization
Tonghua Dongbao Pharmaceutical Co.
4 clinical trials
Clinical trial
A Multi-center, Randomized, Open-label, Parallel-group, Phase Ⅲ Study to Evaluate the Efficacy and Safety of Insulin Aspart Injection in Patients With Diabetes Mellitus Compared to NovoRapid®Status: Completed, Estimated PCD: 2016-08-12
Clinical trial
A Phase 3, Randomized, Open-Label, Multicenter, Active-controlled Trial Comparing Efficacy and Safety of THDB0206 Injection With Insulin Lispro Injection Combined With Insulin Glargine Injection U-100 in Chinese Participants With Type 2 DiabetesStatus: Recruiting, Estimated PCD: 2024-03-30
Clinical trial
An Open-label, Active-controlled, Randomized, Three-cycle, Crossover Trial to Evaluate the Pharmacokinetics and Pharmacodynamics of Single-Dose THDB0206 Injection in Healthy Chinese SubjectsStatus: Completed, Estimated PCD: 2022-06-06
Clinical trial
A Randomized, Open-label, Two-period, Cross-over Trial to Evaluate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Injection Compared With Xultophy® in Healthy Chinese SubjectsStatus: Recruiting, Estimated PCD: 2024-06-16